Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-10 4:30 pm Purchase | 2025-12-03 | 13G | Belite Bio, Inc BLTE | Darwin Global Management, Ltd. | 2,617,094 7.000% | 2,617,094 (New Position) | Filing History |
| 2025-01-21 06:02 am Purchase | 2024-12-31 | 13G | Belite Bio, Inc BLTE | Yu-Hsin Lin | 2,287,070 7.100% | 159,248 (+7.48%) | Filing History |
| 2025-01-21 06:01 am Unchanged | 2024-12-31 | 13G | Belite Bio, Inc BLTE | Lin Bioscience International Ltd. | 17,095,263 53.700% | 0 (Unchanged) | Filing History |
| 2024-02-12 9:08 pm Sale | 2023-12-31 | 13G | Belite Bio, Inc BLTE | Yu-Hsin Lin | 2,127,822 7.300% | -357,486 (-14.38%) | Filing History |
| 2024-02-12 8:40 pm Purchase | 2023-12-31 | 13G | Belite Bio, Inc BLTE | Lin Bioscience International Ltd. | 17,095,263 58.600% | 666,666 (+4.06%) | Filing History |
| 2023-02-15 1:36 pm Purchase | 2022-12-31 | 13G | Belite Bio, Inc BLTE | Yu-Hsin Lin | 2,485,308 9.970% | 2,485,308 (New Position) | Filing History |
| 2023-02-14 08:50 am Purchase | 2022-12-31 | 13G | Belite Bio, Inc BLTE | Lin Bioscience International Ltd. | 16,428,597 65.980% | 16,428,597 (New Position) | Filing History |